Flavokavain B: Chemical Properties and Biological Effects
Flavokavain B, known systematically as 2′-Hydroxy-4′,6′-dimethoxychalcone, is a bioactive compound derived from the kava plant. As a member of the flavokavain family, this molecule has drawn significant scientific interest due to its dual nature: it exhibits promising potential in cancer research while simultaneously showing toxicity in specific cellular environments.
Understanding the chemical structure and biological activity of Flavokavain B is essential for evaluating both the therapeutic potential of kava-derived compounds and the safety profiles of different kava cultivars.
Key Facts
- Source: Found naturally in the kava plant.
- Cancer Research: Demonstrates antiproliferative (inhibiting cell growth) and pro-apoptotic (inducing programmed cell death) effects.
- Toxicity: Acts as a potent liver toxin by inducing oxidative stress.
- Mitigation: Harmful effects on the liver can be reversed using glutathione supplementation.
- Cultivar Variance: Found in significantly higher concentrations in "Two-Day" kava cultivars (e.g., Palisi) than in noble varieties.
Chemical Profile and Identifiers
Flavokavain B is characterized by its specific molecular arrangement, which defines its interaction with biological systems. It has a molar mass of 284.311 g·mol and a chemical formula of C17H16O4.
| Identifier | Value |
|---|---|
| Preferred IUPAC Name | 2′-Hydroxy-4′,6′-dimethoxychalcone |
| CAS Number | 1775-97-9 |
| PubChem CID | 5356121 |
| ChemSpider ID | 4511912 |
| ChEMBL ID | ChEMBL104255 |
| Molar Mass | 284.311 g·mol |
Biological Activity and Medical Potential
Anticancer Properties
Research indicates that Flavokavain B possesses significant chemotherapeutic potential. A systematic review of kava studies suggests that the compound exerts antiproliferative and pro-apoptotic effects across various cancer models. These properties make it a subject of interest for treating epithelial cancers, although data regarding its effect on oral squamous cell carcinoma remains limited.
Hepatotoxicity and Cellular Stress
Despite its potential in oncology, Flavokavain B is recognized as a potent liver toxin. It triggers cell death by disrupting key cellular signaling pathways and inducing oxidative stress—an imbalance between free radicals and antioxidants in the body. Interestingly, this toxicity can be countered through the supplementation of glutathione, a powerful endogenous antioxidant.
Kava Cultivars and Human Safety
The concentration of Flavokavain B varies significantly depending on the type of kava plant used. "Two-Day" cultivars, such as the Palisi variety, contain much higher levels of the compound compared to noble kava varieties.
While the compound's toxicity is evident in laboratory settings, current scientific evidence does not conclusively prove that Flavokavain B is the primary cause of liver toxicity observed in humans consuming kava.
Frequently Asked Questions
What is Flavokavain B?
Flavokavain B is a bioactive compound found in the kava plant, chemically identified as 2′-Hydroxy-4′,6′-dimethoxychalcone.
How does Flavokavain B affect cancer cells?
It exhibits antiproliferative and pro-apoptotic effects, meaning it can inhibit the growth of cancer cells and encourage them to undergo programmed cell death, particularly in epithelial cancer models.
Is Flavokavain B toxic to the liver?
Yes, in laboratory studies, it is a potent liver toxin that causes cell death by inducing oxidative stress and disrupting cellular signaling.
Can the toxic effects of Flavokavain B be reversed?
Research indicates that the harmful effects of Flavokavain B on liver cells can be reversed through the supplementation of glutathione.
Which kava varieties contain more Flavokavain B?
"Two-Day" kava cultivars, such as Palisi, contain significantly higher levels of Flavokavain B than noble kava varieties.
Does Flavokavain B cause liver failure in humans?
While it is toxic in experimental models, current evidence does not conclusively prove that Flavokavain B is responsible for kava-related liver toxicity in humans.